Current treatment of COVID-19 in renal patients: hope or hype?

To date the severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), known as COVID-19, is for clinicians the most difficult global therapeutic problem. In this landscape, the management of patients with chronic kidney disease, acute kidney injury or patients undergoing immunosuppressant thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberto, Palumbo, Francesco, Londrino, Emanuela, Cordova, Giorgia, Gambardella, Pasquale, Niscola, Sara, Dominijanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Im - Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520511/
https://www.ncbi.nlm.nih.gov/pubmed/32986137
http://dx.doi.org/10.1007/s11739-020-02510-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520511/
https://www.ncbi.nlm.nih.gov/pubmed/32986137
http://dx.doi.org/10.1007/s11739-020-02510-0

Ejemplares similares